Navigation Links
Researchers Study Safety of Assisted Reproductive Technologies

Researchers have found that Assisted Reproductive Technologies (ARTs) do not increase the risk of genetic mutations in developing fetuses//. Results of the study in mice will be released in this week’s journal, Proceedings of the National Academy of Sciences.

“Although there have now been more than 3 million humans conceived by some form of ART, there have been very few studies of potential genetic abnormalities resulting from these methods. The results of our study in mice indicate that these methods do not lead to any increased risk of mutations,” said John McCarrey, UTSA professor of biology.

McCarrey and his graduate student, Patricia Murphey, along with collaborators Drs. Ryuzo Yanagimachi and Yukiko Yamazaki, University of Hawaii John A. Burns School of Medicine, and Lee Caperton, Alex McMahan and Christi Walter, UTHSC, compared mice produced by at least five different assisted reproductive technologies – in vitro fertilization, embryo transfer, pre-implantation culture, intracytoplasmic sperm injection and round spermatid injection – with mice produced by natural reproduction. The scientists reviewed the DNA of each group looking for “point mutations,” genetic errors that are known to underlie many genetic diseases in humans.

The analysis was conducted using special mice that have been genetically manipulated to more easily detect point mutations. DNA was extracted from fetuses at mid-gestation, about 10 days past conception.

“We must make conception by assisted reproductive technologies as safe, or even safer than natural conception,” said Dr. Yanagimachi.

ART technologies are now responsible for more than one percent of births in the U.S. and most Western countries. In some countries, such as Denmark, the figure is as high as six percent or more.

“This new study indicates that these methods of in vitro conception are not disrupting naturally occurring processes that are required to di
'"/>




Page: 1 2

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria

Post Your Comments:
(Date:11/27/2009)...LLAS, Nov. 27 Considere...re only 25 years ago, solid organ transplantation ...o the extraordinary men and women who gathered at ...ders came together from medical centers around the... Regional Transplant Institute (BRTI), one of the ...
(Date:11/27/2009)...BUTZ SHAMIR, Israel, Nov. 27 /PRNewswire-FirstCall... ( "Shamir" ), a leading provider of innovative pr...t, announced today that its board of directors had...amount of US$ 10 million (approximately NIS 37.62 ...ive rate of exchange), or approximately US$ 0.609 ...
(Date:11/27/2009)... , SEATTLE, Nov. 27 Al...d record-high Thanksgiving traffic numbers, with m...sgiving, providing a clear picture of what was ser...verage Thanksgiving meal in 2009 weighed in at 2,2... last year,s feast. According to the Allrecipes si...
(Date:11/27/2009)... Three new interactive anatomy educatio... Wilkins expand health sciences learning opportuni... Durham, NC (Vocus) November 27, 2009 -- M...ns (LWW), a division of Wolters Kluwer Health, tod... education apps on the App Store. Clemente’s...
(Date:11/26/2009)...equestering drug tetrathiomolybdate (TM) has been ...of Wilson disease, a disease caused by an overload...uch is known. Very little, however, is known about...new study led by Northwestern University researche...dimensional structure of TM bound to copper-loaded...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
...n decided to stop admitting patients to the Altrin...ty. The decision been taken by NHS managers// who ... Although patient safety is believed to be respo...he elderly will close soon. The day care clinics, ...
...th the International Women’s Day celebrations, an ...Chennai-based Apollo hospitals. Ms. J. Jayalalitha... health care center on Wednesday. // The hea...t women, diseases such as cancer, AIDS, osteoarthr...
...sal fact is that breastfeeding is the best form of...r breastfeeding or the weaning age affect the risk...various platforms. // A new study on this aspec...in the March issue of the American Journal of Clin...
...nston, professor of psychology and a team of Corne...at different areas of the brain react differently ... upon the emotions attached to the memory. The res...vidence of those encounters. They identified w...
...ther Herceptin refusal case in the UK, a 10-year-o...t cancer is seeking the help from her MP in order ...eatment. Katie Morgan's mother, Susan wants to be ... region has received the letter written by Kate re...
...e widespread awareness being propagated by the Ind...hips, as still most of the people don’t even posse...married Celina was busy knitting dreams of life an...put up a tough fight against the disease and socie...
Other Medicine News:Health News:Want to save the child from obesity introduce infant food early: says a study 2Health News:Cure For Autism Could Be Established Through Hamster Studies 2Health News:Misconceptions Put AIDS Patients In Tight-Spot 2
(Date:11/25/2009)..., , RANCHO CORDOVA, Calif., Nov. 25 /PRNe...diary of American Pacific Corporation (Nasdaq: AP...ental Responsibility and Sustainability Award at t...d by the California Manufacturers and Technology A...sociation (IEA) and the Chemical Industry Council ...
(Date:11/25/2009)..., , HARBIN, China, Nov. 25 /PRNe...nc. ("China Sky One Medical" or "the Company") (Na...utical company developing and producing,over-the-c...RC"), today,announced that the Company recently pa...l of Pharmaceutical and Biological Products ("ICPB...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 /PRNewswire/ ...search report is available in its catalogue: ,,...tive ,, http://www.reportlinker.com/p0164330...ve.html ,, Rising incidence of breast cancer i...a principal factor influencing growth in the mammo...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 1Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 2Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 3Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 4Vasogen Receives NASDAQ Notification Related to Minimum Bid Price 13586 1Vasogen Receives NASDAQ Notification Related to Minimum Bid Price 13586 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 1BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 3
...howed Campath May Lead to Overall Survival in Pati...NCISCO, Dec. 9 Bayer HealthCare Pharmaceuticals I...wing that treatment with Campath(R) (alemtuzumab) ...eukemia (CLL) patients who have poor prognostic in...h Annual Meeting of the American Society of Hemato...
...ANCISCO, Dec. 8 Millennium: The Takeda Oncology C...ended follow up of patients from the large, intern... survival improvement for patients with previously...an and prednisone (VcMP). The VELCADE combination ...b-groups, including those with poor prognostic cha...
Other Medicine Technology:Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 2Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 3Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 4Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 5Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 6Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 7Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 8Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 9Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 10Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: